Loading...

The Cannabist Company Holdings Inc.

CBST.NENEO
HealthcareDrug Manufacturers - Specialty & Generic
CA$0.07
CA$0.01(15.38%)

The Cannabist Company Holdings Inc. (CBST.NE) Stock Overview

Explore The Cannabist Company Holdings Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
-10.29%
10.29%
Profit Growth
CA$-0.22
39.74%
EPS Growth
CA$-0.22
47.73%
Operating Margin
-4.65%
78.84%
ROE
1010.60%
39.74%
Dividend Yield
0.00%
Analyst Recommendations data is not available for CBST.NEAnalyst Recommendations details for CBST.NE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

The Cannabist Company Holdings Inc. engages in the cultivation, manufacture, and provision of cannabis products and related services in the United States and internationally. The company offers spanning flower, edibles, oils, and tablets under the Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press, and Amber brand names. It holds licenses in 17 jurisdictions in the United States. The company was formerly known as Columbia Care Inc. and changed its name to The Cannabist Company Holdings Inc. in September 2023. The company was founded in 2012 and is headquartered in New York, New York.

CEO

Mr. David J. Hart

Employees

1,681

Headquarters

680 Fifth Avenue, New York, NY

Founded

2019

Frequently Asked Questions